Jump to content

Nesvacumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by WildCation (talk | contribs) at 15:40, 28 March 2014 (Set CSID to NA). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Nesvacumab
Monoclonal antibody
Type?
SourceHuman
Targetangiopoietin 2
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
Chemical and physical data
FormulaC6440H9966N1722O2008S38
Molar mass144.9 kDa g·mol−1

Nesvacumab is a monoclonal antibody designed for the treatment of cancer.[1]

This drug was developed by Regeneron Pharmaceuticals.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Nesvacumab, American Medical Association.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Nesvacumab&oldid=601667153"